Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jackson, P. E.
Right arrow Articles by Povey, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, P. E.
Right arrow Articles by Povey, A. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 3, 509-513, March 1999
© 1999 Oxford University Press


Short Communications

The relationship between 1,2-dimethylhydrazine dose and the induction of colon tumours: tumour development in female SWR mice does not require a K-ras mutational event

Peta E. Jackson1,2, Donald P. Cooper1,3, Peter J. O'Connor1 and Andrew C. Povey1,5

1 CRC Section of Genome Damage and Repair, Paterson Institute for Cancer Research, Manchester M20 9BX, UK

In this study we have investigated the relationship between the dose of 1,2-dimethylhydrazine (DMH) and the yield (and location) of tumours in a mouse strain susceptible to colon tumour induction. Female SWR mice were injected with 6.8 mg/kg DMH i.p. once a week for 1, 5, 10 and 20 weeks and the animals were followed for almost 2 years. Administration of increasing doses of DMH resulted in a dose-dependent decrease in survival time. Colon tumours developed in 26, 76 and 87% of mice given a total dose of 34, 68 and 136 mg/kg DMH, respectively: no tumours were detected in animals treated with a total dose of 6.8 mg/kg. Most colon tumours (79%) were located in the distal colon with the remainder being found in the mid colon and none were detected in either the proximal colon or small intestine. As mutations in the K-ras gene are thought to be key events in the pathogenesis of human and rodent colon tumours, we determined the frequency of codon 12 and 13 K-ras mutations in these tumours by restriction site mutation analysis and/or DNA sequencing. A total of 50 colon tumour samples were analysed for codon 12 mutations and of these 29 were also screened for codon 13 mutations. No mutations were detected in either of these codons. The mutational activation of the K-ras gene is not an essential step in the development of DMH-induced colon tumours in female SWR mice and if similar considerations apply to humans, then the aetiological role of alkylating agents may be underestimated from the prevalence of K-ras GC->AT transitions in human tumours.

Abbreviations: AOM, azoxymethane; DMH, 1,2-dimethylhydrazine; O6-MeG, O6-methylguanine; NMU, N-methyl-N-nitrosourea; PBS, phosphate-buffered saline; RSM, restriction site mutation.

2 Present addresses: Department of Environmental Health Sciences, School of Hygiene and Public Health, Baltimore, MD 21205, USA and

3 Micromass UK Ltd, Floats Road, Wythenshawe, Manchester M23 9LZ, UK

5 To whom correspondence should be addressed at: School of Epidemiology and Health Sciences, Medical School, University of Manchester, Oxford Road, Manchester M13 9PT, UK


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Hu, G. H. McIntosh, R. K. Le Leu, R. Woodman, and G. P. Young
Suppression of Colorectal Oncogenesis by Selenium-Enriched Milk Proteins: Apoptosis and K-ras Mutations
Cancer Res., June 15, 2008; 68(12): 4936 - 4944.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Y. Chang, J. Boulden, J. B. Katz, L. Wang, T. J. Meyer, A. P. Soler, A. J. Muller, and G. C. Prendergast
Bin1 Ablation Increases Susceptibility to Cancer during Aging, Particularly Lung Cancer
Cancer Res., August 15, 2007; 67(16): 7605 - 7612.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. E. Jackson, P. J. O'Connor, D. P. Cooper, G. P. Margison, and A. C. Povey
Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine
Carcinogenesis, March 1, 2003; 24(3): 527 - 533.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. C. Povey, A. F. Badawi, D. P. Cooper, C. N. Hall, K. L. Harrison, P. E. Jackson, N. P. Lees, P. J. O'Connor, and G. P. Margison
DNA Alkylation and Repair in the Large Bowel: Animal and Human Studies
J. Nutr., November 1, 2002; 132(11): 3518S - 3521.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Takahashi, S. Nakatsugi, T. Sugimura, and K. Wakabayashi
Frequent mutations of the {beta}-catenin gene in mouse colon tumors induced by azoxymethane
Carcinogenesis, June 1, 2000; 21(6): 1117 - 1120.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
P. J. O'Connor, F. C.R. Manning, A. T. Gordon, M. A. Billett, D. P. Cooper, R. H. Elder, and G. P. Margison
Thresholds for Genotoxic Carcinogens: DNA Repair: Kinetics and Thresholds
Toxicol Pathol, May 1, 2000; 28(3): 375 - 381.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.